Literature DB >> 10415424

Orphanin FQ, a novel neuropeptide with anti-stress-like activity.

G Griebel1, G Perrault, D J Sanger.   

Abstract

Potential anxiolytic-like properties of intracerebroventricular (i.c. v.) infusion of orphanin FQ (OFQ), a recently discovered neuropeptide, were investigated in the mouse defense test battery, a well-validated anxiolytic screening test. In this model, Swiss mice are directly confronted with a natural threat (a rat) as well as situations associated with this threat. Primary measures taken during and after rat confrontation were flight, risk assessment, defensive attack and escape attempts. Unlike the anxiolytic drug diazepam (3-10 microgram/5 microliter, i.c.v.), which affected all defensive responses, OFQ (0.3-3 nM/5 microliter) only clearly reduced defensive upright postures and biting reactions. Subjects displayed these latter defensive behaviors upon forced contact with the threat stimulus, a situation which is considered to be highly stressful. These results suggest that the OFQ system may not be primarily involved in anxiety-related responses including cognitive aspects (i. e., risk assessment), while it may play a role in the adaptative responses to unavoidable or extreme stress stimuli. Copyright 1999 Published by Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415424     DOI: 10.1016/s0006-8993(99)01684-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task.

Authors:  Laila Asth; Nataly Correia; Bruno Lobão-Soares; Thereza C Monteiro De Lima; Remo Guerrini; Girolamo Calo'; Vanessa P Soares-Rachetti; Elaine C Gavioli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-16       Impact factor: 3.000

Review 2.  Pharmacology of nociceptin and its receptor: a novel therapeutic target.

Authors:  G Calo'; R Guerrini; A Rizzi; S Salvadori; D Regoli
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 3.  The nociceptin/orphanin FQ receptor (NOP) as a target for drug abuse medications.

Authors:  Nurulain T Zaveri
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

4.  Further characterization of the prototypical nociceptin/orphanin FQ peptide receptor agonist Ro 64-6198 in rodent models of conflict anxiety and despair.

Authors:  Celia Goeldner; Will Spooren; Jürgen Wichmann; Eric P Prinssen
Journal:  Psychopharmacology (Berl)       Date:  2012-01-18       Impact factor: 4.530

5.  Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala.

Authors:  S Meis; H C Pape
Journal:  J Physiol       Date:  2001-05-01       Impact factor: 5.182

Review 6.  A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell.

Authors:  Daniel C Castro; Michael R Bruchas
Journal:  Neuron       Date:  2019-05-08       Impact factor: 17.173

7.  Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.

Authors:  Dirk Faulhammer; Bernd Eschgfäller; Sandra Stark; Petra Burgstaller; Werner Englberger; Jeannette Erfurth; Frank Kleinjung; Johanna Rupp; Sebastian Dan Vulcu; Werner Schröder; Stefan Vonhoff; Hermann Nawrath; Clemens Gillen; Sven Klussmann
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

8.  The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ.

Authors:  Roberto Ciccocioppo; Amalia Fedeli; Daina Economidou; Federica Policani; Friedbert Weiss; Maurizio Massi
Journal:  J Neurosci       Date:  2003-10-15       Impact factor: 6.167

Review 9.  Antidepressant- and anxiolytic-like effects of nociceptin/orphanin FQ receptor ligands.

Authors:  Elaine C Gavioli; Girolamo Calo'
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-21       Impact factor: 3.000

10.  Role of opioid receptor like-1 receptor in modulation of endocrine, immunological, and behavioral responses to the T-cell superantigen staphylococcal enterotoxin A.

Authors:  Elyse M Mallimo; Mike A Ansonoff; John E Pintar; Alexander W Kusnecov
Journal:  J Neuroimmunol       Date:  2009-11-13       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.